Pure Global AI
NCT06289985Not yet recruiting

StrokeNet Thrombectomy Endovascular Platform

STEP: StrokeNet Thrombectomy Endovascular Platform
Medical University of South CarolinaClinicalTrials.govdeviceDevice trial
Verified
Study focus
Disease/Condition
Ischemic Stroke
Drug/Device/Intervention
Endovascular thrombectomy with any FDA-approved category POL or NRY device
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Medical University of South Carolina
Timeline & enrollment
Phase
N/A
Start date
Jun 01, 2024
End date
Sep 01, 2028
Enrollment
2000 participants
Primary outcome

Global disability measured by Modified Rankin Score

Summary

STEP is a Randomized, Multifactorial, Adaptive Platform trial that seeks to optimize the care
 of patients with acute ischemic stroke (AIS) due to large (LVO) or medium vessel occlusions
 (MVO).

ICD-10 classifications
Stroke, not specified as haemorrhage or infarctionSequelae of stroke, not specified as haemorrhage or infarctionCerebral infarctionCerebral infarction, unspecifiedOther cerebral infarction
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06289985
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06289985 through Pure Global AI's free database. This phase not specified trial is sponsored by Medical University of South Carolina and is currently Not yet recruiting. The study focuses on Ischemic Stroke. Target enrollment is 2000 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.